Prot # M14-222An Open-Label, Multicenter Study to Evaluate Long-term Outcomes with ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ II)

  • Flamm, Steven L (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/7/14 → 12/31/20

Funding

  • AbbVie Inc. (Prot #M14-222)